The first-ever treatment for malaria in young babies and infants has been approved. On Tuesday, Novartis announced it had received approval for the treatment, Coartem Baby (known as Riamet Baby in ...

The medicine, called Coartem Baby (also known as Riamet Baby), was approved by Switzerland’s health agency, Swissmedic. HealthDay News — A new malaria treatment has been approved for newborns and ...

Patients who are infected with malaria and dengue virus receive treatment in an isolation ward at a hospital in Pakistan. Drugs known as artemisinins have been remarkably effective in helping malaria ...

The first new malaria treatment in decades holds promise against rising drug resistance after Swiss drugmaker Novartis announced it was as effective at treating the disease as established treatments.

A malaria drug could help immune-compromised people who can't shake off babesiosis, a tick-borne parasitic infection, a new study says. The drug tafenoquine helped cure four New England patients whose ...

KAMPALA, Uganda (AP) — Alice Nekesa did not know she was infected with malaria-causing parasites until it was too late. She was in the fourth month of pregnancy last year when she started bleeding, a ...

This October 2024 image provided by Novartis shows GanLum, a new anti-malaria treatment, at a manufacturing facility in Slovenia. (Novartis via AP) (Uncredited) NEW YORK – Researchers on Wednesday ...

NEW YORK (AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. Sam Darnold and Seahawks ...

At the turn of the millennium, a new class of drugs derived from ancient Chinese herbal medicine revolutionized malaria care. Artemisinin's, as they're called, are based on extracts from the sweet ...